The JPMorgan Healthcare Conference, hosted by JPMorgan Chase, is one of the largest and most influential healthcare investment symposiums in the industry. It started in 1983 and is held annually in San Francisco, typically in January.

JPMHC 2024

The conference brings together industry leaders, emerging fast-growth companies, innovative technology creators, and members of the investment community. It’s a platform where companies present their latest developments, strategies, and insights into the healthcare sector, including pharmaceuticals, biotechnology, healthcare services, and medical devices.

Over the years, this event has grown significantly in size and scope. It’s now a key venue for major announcements in the healthcare sector and is closely watched by investors, industry professionals, and analysts worldwide.

What did I follow?

My Summary

The 2024 JPMorgan Healthcare Conference highlighted several key developments in healthcare. Morgan Health expressed commitment to controlling healthcare costs and aiding employers in this effort. Samsung Biologics announced plans to expand biomanufacturing capacity and diversify its portfolio. There was a notable focus on consumer-centric healthcare, emphasizing patient-focused strategies. The conference also spotlighted the growing role of Artificial Intelligence in healthcare, from improving diagnosis accuracy to managing chronic diseases. Additionally, the rising costs of cancer care were addressed, with initiatives like Cleveland Clinic’s collaboration with IBM on quantum computing for biomedical sciences​ Personal Experience in 2024: Share your personal experiences, key takeaways, and observations from the 2024 conference. Highlight specific sessions, innovations, or discussions that were impactful.

Key Deals

  • Johnson & Johnson and Ambrx: Johnson & Johnson bought Ambrx for $2 billion, focusing on antibody-drug conjugate development.
  • Merck & Co. and Harpoon Therapeutics: Merck & Co. acquired Harpoon Therapeutics for $680 million, expanding its biopharmaceutical portfolio.
  • Novartis and Calypso Biotech: Novartis purchased Calypso Biotech for $250 million upfront, with $175 million in potential milestones, enhancing its autoimmune disease treatments.
  • Novartis and Shanghai Argo Biopharmaceutical: Novartis licensed two RNAi therapeutics for cardiovascular conditions from Shanghai Argo Biopharmaceutical, with an upfront payment of $185 million and a potential total of $4.2 billion.
  • In 2023, one of the main focuses was on the return to in-person meetings after a period of virtual conferences due to the pandemic. This return was seen as a positive step towards normalcy and provided an opportunity for more direct interaction and networking among healthcare professionals.
  • In 2022, the JPMorgan Healthcare Conference was significant for several reasons. The conference saw a plethora of licensing and research deals, indicating a strong interest in innovative technologies. Notably, there was a large presence of digital health and health tech companies, reflecting an industry trend towards integrating artificial intelligence and machine learning in drug discovery and patient care.
  • For the 2021 conference, companies like ImmunoGen, IDEAYA Biosciences, Jounce Therapeutics, and Puma Biotechnology provided updates on their product pipelines and regulatory plans. ImmunoGen discussed its drug for ovarian cancer, IDEAYA Biosciences focused on its MAT2A inhibitor for solid tumors, Jounce Therapeutics shared updates on its ILT4 inhibitor for advanced solid tumors, and Puma Biotechnology outlined plans for evaluating its drug Nerlynx in biomarker-defined cancers.

Hot Takes

  • The rising costs of cancer care are a significant concern globally. Factors contributing to this increase include the high price of new cancer drugs and therapies, the growing prevalence of cancer as populations age, and the need for long-term and sometimes lifelong treatment.
  • The global digital health market is projected to grow significantly in the coming years. In 2024, it is estimated to be valued at approximately USD 296.46 billion. This market is expected to continue its growth trajectory, reaching around USD 655.57 billion by 2029, expanding at a compound annual growth rate (CAGR) of 17.20% during this period. This growth is driven by factors like increased adoption of digital healthcare solutions, advancements in artificial intelligence, IoT, and big data, as well as the rising use of mobile health applications and government initiatives supporting digital health. However, concerns regarding the security of patient data might pose challenges to this growth.


  • No one talks about the care giving crisis, and how the health industry is going to solve it. Illnessed like cancer leave the patient confused and hopeless event especially because care management is not solved. Confused Patient

Upcoming Healthcare Conferences

  • CES® 2024: Scheduled for January in Las Vegas, this conference focuses on innovative technologies and solutions in healthcare. (January 2024)
  • IMSH 2024: This event in San Diego features immersive experiences and workshops in healthcare simulation. (January 2024)
  • HLTH 2024: In Las Vegas, this conference focuses on personalized experiences, networking, and career advancement in healthcare. (October 2024)
  • Digital Healthcare Innovation Summit: Taking place in La Jolla, California, it brings together healthcare innovators and investors. (Date not specified)
  • Pharmaceutical Automation and Digitalisation Congress 2024: In Zurich, this event focuses on digital transformation in the pharmaceutical sector. (November 2024)
  • DTx West 2024: A summit in Los Angeles for executives and policymakers in digital therapeutics. (February 2024)
  • AHA Rural Health Care Leadership Conference 2024: In Orlando, this conference addresses strategies for improving access to care and health equity. (February 2024)
  • ViVE 2024: Held in Los Angeles, it connects providers and payers with technology solutions. (February 2024)
  • HIMSS Global Health Conference & Exhibition: In Orlando, this gathering aims to harness information and technology in healthcare. (March 2024)
  • 2024 Executive Leadership Summit: In Phoenix, focusing on health care access and improving patient outcomes. (February 2024)